title: Who should manage germ cell tumours of the testis?
authors.affiliation: The Wessex Medical Oncology Unit, Royal South Hants Hospital, Southampton, UK.
authors.forename: G M
authors.initials: GM
authors.lastname: Mead
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002173:Cancer Care Facilities; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D018237:Germinoma / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000628:therapy; D018239:Seminoma / Q000473:pathology / Q000556:secondary / Q000628:therapy; D013724:Teratoma / Q000473:pathology / Q000556:secondary / Q000628:therapy; D013736:Testicular Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin